A clinical trial conducted by Prof. Alexandra Durr's team (Sorbonne University.AP-HP) at the Paris Brain Institute and the Pitié-Salpêtrière Hospital AP-HP shows that despite the hopes raised in ...
The FDA has issued a CRL to Biohaven regarding the NDA for troriluzole for the treatment of adults with spinocerebellar ataxia.
Parkinson's disease is a degenerative central nervous system disorder that often impairs motor skills, speech and other functions. We discovered a large Chinese family showing primarily parkinsonism ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Riluzole did not improve clinical or ...
Biohaven is proposing troriluzole for the treatment of spinocerebellar ataxia, a group of rare, genetic diseases that lead to the progressive loss of control over movement.
In two studies of mice, researchers showed that a drug, engineered to combat the gene that causes spinocerebellar ataxia type 2 (SCA2), might also be used to treat amyotrophic lateral sclerosis (ALS).
Adult-onset SCA2 is characterized by progressive ataxia, extremely slow saccades, dysarthria, supranuclear ophthalmoplegia, cognitive impairment, peripheral neuropathy, as well as action or postural ...
National Institute of Neurological Disorders and Stroke (NINDS) researchers in two studies of mice, showed that a drug, engineered to combat the gene that causes spinocerebellar ataxia type 2 (SCA2), ...
A 23 year-old man presented with slowly progressive gait and limb ataxia, slurred speech and nystagmus over 10 years. Spinocerebellar Ataxia (SCA): (Left) T2-weighted axial MRI; (Middle) T1-weighted ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cadent Therapeutics, a clinical stage biopharmaceutical company focused on the development of therapies to improve the lives of patients with movement, mood, and ...
DUBLIN--(BUSINESS WIRE)--The "Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Spinocerebellar Ataxia - Pipeline Review, H2 ...
Patient 1, a 49-year-old man with titubation, dizziness, and loss of balance from the age of 34 years, had deteriorating speech and handwriting. Cerebellar signs included moderate gait ataxia, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results